Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with respect to the Improvement of quality of life: DLQI and SF-36 Results of the PRIME Study - Augustin, M.; Thaci, D.; Reich, K.; Mrowietz, U.; Kneidl, J.; Hentschke, C.; Simang, M.; Sieder, C.; Melzer, N.; Sticherling, Michael (2017)
EVALuna2:34359